Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI (DEBATE)
Sponsor: Central Finland Hospital District
A NA clinical study on Coronary Artery Disease, this trial is actively recruiting participants. The trial is conducted by Central Finland Hospital District and has accumulated 6 data snapshots since 2022. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
-
Nov 2022 — Dec 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2021 — Nov 2022 [monthly]
Not Yet Recruiting NA
▶ Show 1 earlier version
-
Apr 2021 — Oct 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Central Finland Hospital District
- Central Hospital of Lapland
- Centre Hospitalier de La Rochelle
- Helsinki University Central Hospital
- Hospital Universitario de Cabuenes
- Kuopio University Hospital
- Norfolk and Norwich University Hospitals NHS Foundation Trust
- North Karelia Central Hospital
- Oulu University Hospital
- Päijät Häme Central Hospital
- Satakunta Central Hospital
- Tampere University Hospital
- Turku University Hospital
- University Hospital Carl Gustav Carus
- University Hospital, Saarland
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Dresden, Germany , Helsinki, Finland , Homburg, Germany , Joensuu, Finland , Jyväskylä, Finland , Kuopio, Finland , La Rochelle, France , Lahti, Finland , Norwich, United Kingdom , Oulu, Finland and 4 more locations